2021
DOI: 10.31128/ajgp-04-20-5363
|View full text |Cite
|
Sign up to set email alerts
|

Fracture risk prediction and the decision to treat low bone density

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 13 publications
0
4
0
Order By: Relevance
“…With the growth of the global population and the aging problem, the incidence of osteoporosis among the elderly population has become a global public health issue. Fragility fractures caused by osteoporosis, especially vertebral fractures, are associated with high mortality and disability rates [3]. However, the majority of osteoporosis patients are asymptomatic at an early stage, so early diagnosis and interventions through medical imaging examinations are critical to prevent the occurrence of complications [4].…”
Section: Introductionmentioning
confidence: 99%
“…With the growth of the global population and the aging problem, the incidence of osteoporosis among the elderly population has become a global public health issue. Fragility fractures caused by osteoporosis, especially vertebral fractures, are associated with high mortality and disability rates [3]. However, the majority of osteoporosis patients are asymptomatic at an early stage, so early diagnosis and interventions through medical imaging examinations are critical to prevent the occurrence of complications [4].…”
Section: Introductionmentioning
confidence: 99%
“…However, the Garvan model's overestimation has no negative clinical impact since high-risk individuals would be recommended for treatment regardless. There is evidence suggesting that the Garvan model's predicted risk is consistent with the clinical decision-making [ 30 , 31 ].…”
Section: Discussionmentioning
confidence: 99%
“…However, the Garvan model's overestimation has no negative clinical impact since high-risk individuals would be recommended for treatment regardless. There is evidence suggesting that the Garvan model's predicted risk is consistent with the clinical decision-making [23,24].…”
Section: Discussionmentioning
confidence: 99%